Company intelligence / Profile preview

eye.gnos consulting

Ownership: Private
Development stage: Commercial

Overview

eye.gnos consulting is a specialized consultancy providing strategic support in immunology and ophthalmology for all aspects of preclinical to clinical drug development. The team brings extensive academic research experience as well as leadership roles in global pharma R&D. They offer expertise across regulatory strategy, clinical trial design/execution (phases 1–4), KOL management, due diligence for licensing deals, imaging analysis for retina studies, document preparation for regulatory submissions/marketing materials, and more. Their focus is on helping pharma/biotech companies advance programs in autoimmune/inflammatory diseases and ophthalmic indications.

Therapeutic areas: ImmunologyDermatologyGastroenterologyOphthalmologyNeurology
Modalities: small moleculesbiologicsmedical devices
Industry: Consulting

Beyond the preview

Go deeper on eye.gnos consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on eye.gnos consulting.

Explore the full profile